NASDAQ:TGAN Transphorm (TGAN) Stock Price, News & Analysis → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free TGAN Stock Alerts $4.78 0.00 (0.00%) (As of 06/7/2024 ET) Add Compare Share Share Today's Range$4.77▼$4.8150-Day Range$4.78▼$4.9252-Week Range$1.94▼$4.96Volume50,895 shsAverage Volume331,134 shsMarket Capitalization$296.17 millionP/E RatioN/ADividend YieldN/APrice Target$5.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Transphorm alerts: Email Address Transphorm MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside20.3% Upside$5.75 Price TargetShort InterestHealthy3.83% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$27,368 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.51 out of 5 starsComputer And Technology Sector546th out of 576 stocksSemiconductors & Related Devices Industry84th out of 85 stocks 2.0 Analyst's Opinion Consensus RatingTransphorm has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageTransphorm has received no research coverage in the past 90 days.Read more about Transphorm's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.83% of the float of Transphorm has been sold short.Short Interest Ratio / Days to CoverTransphorm has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Transphorm has recently decreased by 10.37%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTransphorm does not currently pay a dividend.Dividend GrowthTransphorm does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TGAN. Previous Next 0.6 News and Social Media Coverage MarketBeat Follows1 people have added Transphorm to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Transphorm insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $27,368.00 in company stock.Percentage Held by InsidersOnly 2.47% of the stock of Transphorm is held by insiders.Percentage Held by Institutions66.45% of the stock of Transphorm is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Transphorm's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Transphorm is -6.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Transphorm is -6.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTransphorm has a P/B Ratio of 14.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Transphorm's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad HedgeyeNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY About Transphorm Stock (NASDAQ:TGAN)Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.Read More TGAN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TGAN Stock News HeadlinesMay 25, 2024 | insidertrades.comKatharina G. Mcfarland Sells 3,996 Shares of Transphorm, Inc. (NASDAQ:TGAN) StockMay 20, 2024 | businesswire.comSt. Charles County Dermatologic Surgery Joins Epiphany DermatologyMay 20, 2024 | businesswire.comTransphorm's SuperGaN at PCIM 2024: Surpassing SiC and e-mode GaN Capabilities in High Power SystemsApril 24, 2024 | businesswire.comTransphorm and Weltrend Semiconductor Release New Integrated GaN System-in-PackagesMarch 26, 2024 | prnewswire.comURGENT: The M&A Class Action Firm Encourages Shareholders of Transphorm, Inc. to Take Action Before the Merger Vote on April 9, 2024 - TGANMarch 13, 2024 | businesswire.comTRANSPHORM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Transphorm, Inc. - TGANMarch 12, 2024 | stockhouse.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates JNPR, TGAN, HMSTFebruary 20, 2024 | finance.yahoo.comTransphorm Announces Fiscal 2024 Third Quarter Results and Provides Business UpdateFebruary 20, 2024 | businesswire.comTransphorm Announces Fiscal 2024 Third Quarter Results and Provides Business UpdateJanuary 20, 2024 | stockhouse.comSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates JNPR, TGAN, TASTJanuary 17, 2024 | finance.yahoo.comTransphorm Announces Two 4-Lead TO-247 Devices, Expanding Product Portfolio for High Power Server, Renewable, Industrial Power ConversionJanuary 11, 2024 | tmcnet.comTGAN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Transphorm, Inc. Is Fair to ShareholdersJanuary 11, 2024 | msn.comRenesas to buy Transphorm to expand power portfolio with GaN technologyJanuary 11, 2024 | markets.businessinsider.comTransphorm, Canaan And Other Big Stocks Moving Higher In Thursday's Pre-Market SessionSee More Headlines Receive TGAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Transphorm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/08/2024Next Earnings (Estimated)6/25/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Semiconductors & related devices Sub-IndustryN/A Current SymbolNASDAQ:TGAN CUSIPN/A CIK1715768 Webwww.transphormusa.com Phone805-456-1300FaxN/AEmployees128Year FoundedN/APrice Target and Rating Average Stock Price Target$5.75 High Stock Price Target$8.00 Low Stock Price Target$3.50 Potential Upside/Downside+20.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,600,000.00 Net Margins-177.91% Pretax Margin-177.91% Return on Equity-149.03% Return on Assets-86.65% Debt Debt-to-Equity RatioN/A Current Ratio1.69 Quick Ratio0.88 Sales & Book Value Annual Sales$16.51 million Price / Sales17.94 Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book14.48Miscellaneous Outstanding Shares61,960,000Free Float60,430,000Market Cap$296.17 million OptionableNot Optionable Beta0.57 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Primit A. Parikh Ph.D. (Age 52)Co-Founder, President, CEO & Director Comp: $390.66kMr. Cameron McAulay (Age 48)Chief Financial Officer Comp: $350.66kDr. Umesh K. Mishra Ph.D. (Age 66)Chairman & CTO Comp: $180kMr. Philip ZukSenior Vice President of Business Development & MarketingMr. Tushar DhayagudeVice President of Worldwide Sales & FAEMr. Randy BergHuman Resources LeaderMr. Sal BarlettSenior Vice President of OperationsMore ExecutivesKey CompetitorsHimax TechnologiesNASDAQ:HIMXSMART GlobalNASDAQ:SGHChipMOS TECHNOLOGIESNASDAQ:IMOSAlpha and Omega SemiconductorNASDAQ:AOSLNavitas SemiconductorNASDAQ:NVTSView All CompetitorsInsiders & InstitutionsKatharina G McfarlandSold 3,996 sharesTotal: $19,540.44 ($4.89/share)Virtu Financial LLCBought 17,064 shares on 5/20/2024Ownership: 0.028%Gabelli Funds LLCBought 284,200 shares on 5/15/2024Ownership: 0.459%GABELLI & Co INVESTMENT ADVISERS INC.Bought 233,600 shares on 5/15/2024Ownership: 0.377%Quadrature Capital LtdBought 15,539 shares on 5/15/2024Ownership: 0.025%View All Insider TransactionsView All Institutional Transactions TGAN Stock Analysis - Frequently Asked Questions Should I buy or sell Transphorm stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TGAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TGAN, but not buy additional shares or sell existing shares. View TGAN analyst ratings or view top-rated stocks. What is Transphorm's stock price target for 2024? 2 Wall Street analysts have issued 1-year target prices for Transphorm's stock. Their TGAN share price targets range from $3.50 to $8.00. On average, they anticipate the company's stock price to reach $5.75 in the next twelve months. This suggests a possible upside of 20.3% from the stock's current price. View analysts price targets for TGAN or view top-rated stocks among Wall Street analysts. How have TGAN shares performed in 2024? Transphorm's stock was trading at $3.65 at the start of the year. Since then, TGAN stock has increased by 31.0% and is now trading at $4.78. View the best growth stocks for 2024 here. When is Transphorm's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 25th 2024. View our TGAN earnings forecast. What other stocks do shareholders of Transphorm own? Based on aggregate information from My MarketBeat watchlists, some companies that other Transphorm investors own include Adobe (ADBE), American Battery Technology (ABML), Capricor Therapeutics (CAPR), Ciena (CIEN), Editas Medicine (EDIT), Eros STX Global (EROS), Grayscale Ethereum Classic Trust (ETC) (ETCG), Freeport-McMoRan (FCX) and Franco-Nevada (FNV). Who are Transphorm's major shareholders? Transphorm's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.42%), Gabelli Funds LLC (0.46%), GABELLI & Co INVESTMENT ADVISERS INC. (0.38%), Virtu Financial LLC (0.03%), Quadrature Capital Ltd (0.03%) and Gamco Investors INC. ET AL (0.02%). Insiders that own company stock include Katharina G Mcfarland and Kelly Smales. View institutional ownership trends. How do I buy shares of Transphorm? Shares of TGAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TGAN) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Transphorm, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Transphorm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.